A world-renowned researcher’s seven tips for expectant mothers with type 1, type 2, or gestational diabetes

Details on monthly test strip subscription plan and our first impressions.

Coming to US in Spring 2017: What it is, what it isn’t, and how to get it

Tripling my carbs --> 5 fewer hours in-range per day, 64% more insulin (!), & more lessons learned.

$99 device makes pump and CGM data viewable to Android smartphone users. Plus, a first look at cool pattern recognition in the Sugar.IQ app with IBM Watson

The artificial pancreas is here for those willing to build their own; what can manufacturers learn from OpenAPS?

Tighter requirements for home meters. What does this mean for current and future blood glucose monitors?

The diaTribe Foundation convenes key diabetes experts to discuss glycemic outcomes beyond A1C on July 21, 2017, in Bethesda, MD

How to overcome the most frustrating diabetes landmine

Ginger Vieira and Jennifer Smith’s month-to-month guide for managing blood sugars, nutrition, exercise, and mental health during pregnancy

“Adam, what do you eat when you’re on a plane?” My six go-to strategies from hundreds of flights and airports

The lame food advice at Adam Brown's diagnosis, why it didn’t work, and Adam's #1 Bright Spot solution

Expected in 2017. Plus, the latest in the pipeline, including concentrated insulin systems and the Horizon Automated Glucose Control System

A six-week study of Tandem’s first automated insulin delivery device with Dexcom’s G5 CGM

A workshop hosted by the JDRF and Helmsley Charitable Trust brought together leaders in the field to discuss opportunities and advances in the treatment and possible...

First trial next month, launch expected in 2-3 years; Dexcom CGM included; a big commitment to diabetes tech innovation from an insulin company

The diaTribe Foundation and TCOYD host discussion at ADA focusing on access, outcomes beyond A1c, and future expectations

How it works and why it could help with exercise challenges. Plus, how diaTribe readers can try it for free

A recent trial comparing once-weekly GLP-1 agonists semaglutide and Trulicity found improved A1c and double the weight loss with semaglutide

Comparing Medtronic’s MiniMed 670G to injections and pumps in people with type 1 diabetes, with and without CGM; enrollment to open in May at some trial locations